Shares in Bruker BioSciences declined 12 percent for the five-day trading period ended Tuesday. The firm's stock dropped steadily from closing at $5.43 last Wednesday to $4.75 at the close of trading on Tuesday, with trading volume unusually high over the last few days. The only news from the firm was a molecular diagnostics alliance announced on Tuesday (see Briefs).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.